BUFFALO, N.Y., — Many childhood cancers start with a hijacking at the molecular level. A group of abnormal proteins known as fusion proteins aberrantly engage with a collection of proteins that ...

"Emerging Fusion Protein Technologies Drive Innovation in Targeted Therapies Across Autoimmune, Cancer, Metabolic, and ...

Researchers discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, simulations, ...

Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they ...

Washington State University researchers have found a way to modulate a common virus protein to prevent viruses from entering ...

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

MEMPHIS, Tenn. – December 3, 2025) Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities.

Scientists are using artificial intelligence to develop nasal antivirals designed to stop viruses such as influenza and COVID ...